Spero Therapeutics, Inc.
Status: Publicly traded
Direct answer
Spero Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SPRO.
Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases within the United States. The company's pipeline includes several key therapeutic candidates: tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic...
Can you invest in Spero Therapeutics, Inc.?
Yes. Spero Therapeutics, Inc. trades publicly on NASDAQ as SPRO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Spero Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.